Guess the Religion. Stupid Bitch fucked by her own belief.

Cottonmouth

Alfrescian
Loyal
Joined
Oct 3, 2016
Messages
35,356
Points
113

Woman in S'pore, allegedly influenced by church friends, takes ivermectin for Covid-19 & ends up in A&E​

Her friends from the church also convinced her that mRNA vaccines are against their religion.
Zi Shan Kow |
clock.png
October 04, 2021, 01:16 PM
covid-19-hospital-ivermectin-singapore.jpg


Follow us on Telegram for the latest updates: https://t.me/mothershipsg

A woman in Singapore has taken to Facebook to call out the irresponsible recommendation and use of parasitic treatment drug ivermectin for Covid-19 after her mother was hospitalised for taking it without proper doctor's prescription and advice.


The daughter, Vanessa Koh Wan Ling, shared in a Facebook post on Oct. 3 an account of what allegedly happened to her mother, and went as far as naming the people involved in procuring the drug and recommending its usage.

Admitted to A&E​


According to the post, Koh's mother suffered from six side effects when she was admitted to the hospital, all of which are the result of consuming ivermectin.
The symptoms included vomiting, severe joint pain, and the inability to walk and stand.

Influenced by church friends​


According to Koh, her mother was allegedly influenced to take ivermectin by two friends who attend the same church in Singapore.
In her post, she shared screen shots that allegedly showed her mother's conversations with the church friends.
Koh claimed the friends managed to convince her mother that taking mRNA vaccines was against their religion, and that "if they are allowed to take, Jesus would reach out to them directly" to register his approval.

ivermectin-woman-take-church-friends-01.jpg
Photo via Vanessa Koh Wan Ling/FB.


ivermectin-woman-take-church-friends-02.jpg
Photo via Vanessa Koh Wan Ling/FB.


ivermectin-woman-take-church-friends-singapore-03.jpg
Photo via Vanessa Koh Wan Ling/FB.



Koh had registered her mother for the Sinopharm vaccine, which is an approved vaccine that is not mRNA based.
However, her mother's friends allegedly claimed that doing so was also taboo, and that her mother will not go to heaven after taking the second jab.

Encouraged to take ivermectin​


The two friends also allegedly convinced Koh's mother that ivermectin can help to "purge out" the vaccine and Covid-19.
It was alleged that Koh's mother gained access to the drug from another church acquaintance, who was also named, and was provided instructions on the drug dosage.

ivermectin-woman-take-church-friends-singapore-04.jpg
Photo via Vanessa Koh Wan Ling/FB.


ivermectin-woman-take-church-friends-05.jpg
Photo via Vanessa Koh Wan Ling/FB.


ivermectin-woman-take-church-friends-06.jpg
Photo via Vanessa Koh Wan Ling/FB.


Strained mother and daughter relationship​


Koh said she could not get through to her mother, even though her mother's choice to take ivermectin "didn't make sense".
Caught between a rock and a hard place -- either cut ties with her mother or let her mother have her way -- as her mother would still have consumed ivermectin, the only silver lining was that Koh could still inform doctors about the drugs ingested, which would inform treatment options.

ivermectin-tablets.jpg
Photo via Vanessa Koh Wan Ling/FB.

As a result of the hospitalisation, the daughter warned others not to "feel that [they] know better than the doctors because of Google".
"Discuss with your family, no matter how you feel your good friends are better because they are more pious," she advised others in her post.
This was because, the daughter wrote, the person sitting outside the A&E was not the church friends, but her.

Use of ivermectin for Covid-19​


Ivermectin is a medication used to treat parasite infestations in animals and humans.
Recently, poorly-supported claims of its effectiveness in preventing and treating Covid-19 in humans have caused a surge in demand for the drug.
In Singapore, ivermectin is only approved for the treatment of parasitic worm infections.
The Health Sciences Authority (HSA) in Singapore have warned that it will take strong enforcement action against those who illegally sell and supply it.
 
Studies in indian hospital in Bhettiar showed ivermectin to be 83 % effective when distributed to their hospital staff against those that were not given.
 
The company which created ivermectin has rebranded the product and decided yo sell it for USD700 for a 5 day dose

October 2, 20217:27 AM +08Last Updated 3 days ago

Healthcare & Pharmaceuticals

Merck pill seen as 'huge advance,' raises hope of preventing COVID-19 deaths​

By Deena Beasley and Carl O'donnell




5 minute read










0 seconds of 0 seconds





  • Summary
  • Merck will seek U.S. approval for pill as soon as possible
  • If approved, would be 1st oral antiviral COVID-19 drug
  • Merck shares rally, some vaccine makers fall
  • U.S. government to buy 1.7 mln courses at $700 each
Oct 1 (Reuters) - An experimental antiviral pill developed by Merck & Co (MRK.N) could halve the chances of dying or being hospitalized for those most at risk of contracting severe COVID-19, according to data that experts hailed as a potential breakthrough in how the virus is treated.
If it gets authorization, molnupiravir, which is designed to introduce errors into the genetic code of the virus, would be the first oral antiviral medication for COVID-19.
Merck and partner Ridgeback Biotherapeutics said they plan to seek U.S. emergency use authorization for the pill as soon as possible and to make regulatory applications worldwide.
"An oral antiviral that can impact hospitalization risk to such a degree would be game-changing," said Amesh Adalja, senior scholar at the Johns Hopkins Center for Health Security.

Current treatment options include Gilead Sciences Inc's (GILD.O) infused antiviral remdesivir and generic steroid dexamethasone, both of which are generally only given once a patient has already been hospitalized.
"This is going to change the dialogue around how to manage COVID-19," Merck Chief Executive Robert Davis told Reuters.
Existing treatments are "cumbersome and logistically challenging to administer. A simple oral pill would be the opposite of that," Adalja added.
The results from the Phase III trial, which sent Merck shares up more than 9%, were so strong that the study is being stopped early at the recommendation of outside monitors.

Shares of Atea Pharmaceuticals Inc (AVIR.O), which is developing a similar COVID-19 treatment, were up more than 21% on the news.
Shares of COVID-19 vaccine makers Moderna Inc (MRNA.O) were off more than 10%, while Pfizer (PFE.N) was down less than 1%.
Jefferies analyst Michael Yee said investors believe "people will be less afraid of COVID and less inclined to get vaccines if there is a simple pill that can treat COVID."
Pfizer and Swiss drugmaker Roche Holding AG (ROG.S) are also racing to develop an easy-to-administer antiviral pill for COVID-19. For now, only antibody cocktails that have to be given intravenously are approved for non-hospitalized patients.

White House COVID-19 response coordinator Jeff Zients said on Friday that molnupiravir is "a potential additional tool... to protect people from the worst outcomes of COVID," but added that vaccination "remains far and away, our best tool against COVID-19."
A planned interim analysis of 775 patients in Merck's study looked at hospitalizations or deaths among people at risk for severe disease. It found that 7.3% of those given molnupiravir twice a day for five days were hospitalized and none had died by 29 days after treatment. That compared with a hospitalization rate of 14.1% for placebo patients. There were also eight deaths in the placebo group.
"Antiviral treatments that can be taken at home to keep people with COVID-19 out of the hospital are critically needed,” Wendy Holman, Ridgeback's CEO, said in a statement.
The Merck logo is seen at a gate to the Merck & Co campus in Rahway, New Jersey, U.S., July 12, 2018. REUTERS/Brendan McDermid

An experimental COVID-19 treatment pill called molnupiravir being developed by Merck & Co Inc and Ridgeback Biotherapeutics LP, is seen in this undated handout photo released by Merck & Co Inc and obtained by Reuters May 17, 2021. Merck & Co Inc/Handout via REUTERS

The Merck logo is seen at a gate to the Merck & Co campus in Rahway, New Jersey, U.S., July 12, 2018. REUTERS/Brendan McDermid



1/2
An experimental COVID-19 treatment pill called molnupiravir being developed by Merck & Co Inc and Ridgeback Biotherapeutics LP, is seen in this undated handout photo released by Merck & Co Inc and obtained by Reuters May 17, 2021. Merck & Co Inc/Handout via REUTERS
Read More

'A HUGE ADVANCE'

Scientists welcomed the potential new treatment to help prevent serious illness from the virus, which has killed almost 5 million people around the world, 700,000 of them in the United States.
“A safe, affordable, and effective oral antiviral would be a huge advance in the fight against COVID," said Peter Horby, a professor of emerging infectious diseases at the University of Oxford.
The study enrolled patients with laboratory-confirmed mild-to-moderate COVID-19, who had symptoms for no more than five days. All patients had at least one risk factor associated with poor disease outcome, such as obesity or older age.
Drugs in the same class as molnupiravir have been linked to birth defects in animal studies. Merck has said similar studies of molnupiravir – for longer and at higher doses than used in humans – indicate that the drug does not affect mammalian DNA.

Merck said viral sequencing done so far shows molnupiravir is effective against all variants of the coronavirus including the highly transmissible Delta, which has driven the recent worldwide surge in hospitalizations and deaths.
It said rates of adverse events were similar for both molnupiravir and placebo patients, but did not give details.
Merck has said data shows molnupiravir is not capable of inducing genetic changes in human cells, but men enrolled in its trials had to abstain from heterosexual intercourse or agree to use contraception. Women of child-bearing age in the study could be pregnant and also had to use birth control.
The U.S. drugmaker said it expects to produce 10 million courses of the treatment by the end of 2021.

The company has a U.S. government contract to supply 1.7 million courses of molnupiravir at a price of $700 per course.
Davis said Merck has similar agreements with other governments, and is in talks with more. Merck said it plans a tiered pricing approach based on country income criteria.
The U.S. government has the option to purchase up to an additional 3.5 million treatment courses if needed, a U.S. health official told Reuters. The official asked to remain anonymous because they were not authorized to comment publicly on the contract.
Merck has also agreed to license the drug to several India-based generic drugmakers, which would be able to supply the treatment to low- and middle-income countries.

Molnupiravir is also being studied in a Phase III trial for preventing infection in people exposed to the coronavirus.
Merck officials said it is unclear how long the FDA review will take, although Dean Li, head of Merck's research labs, said, "they are going to try to work with alacrity on this."
Reporting by Deena Beasley and Carl O'Donnell; Additional reporting by Josephine Mason, and Ahmed Aboulenein; Editing by Lincoln Feast, Kirsten Donovan, Alexander Smith, Bill Berkrot and Sonya Hepinstall
 
161 comments on Sg Reddit about this :
 
Last edited:
That's because Ivermectin as a medicine to treat parasites works well for the Kelings who are dirty parasites themselves.
I think you got it wrong. Its because chinese behave like parasites.
 
But patients DO KNOW MORE THAN DOCTORS!

https://www.health.harvard.edu/blog...are-exert-your-patient-autonomy-2018050713784

Take control of your health care (exert your patient autonomy)​

iStock_78445461_MEDIUM

May 7, 2018
Autonomy means being in control of your own decisions without outside influence — in other words, that you are in charge of yourself. It is considered an essential development step toward maturity. We all make decisions about how to live our lives, although sometimes we have less choice than we might like.

When it comes to your health care, how much autonomy is the right amount?​

There’s lots of interest in what the term means. Here’s a definition from MedicineNet:
Patient autonomy: The right of patients to make decisions about their medical care without their health care provider trying to influence the decision. Patient autonomy does allow for health care providers to educate the patient but does not allow the health care provider to make the decision for the patient.
This can be a hard line to navigate. In the past, physicians made all the decisions for their patients. They would plan the care, prescribe the treatment, and the patient would either comply or not. The word “comply” is itself pejorative. We have moved into a much more enlightened era of care, and many physicians seek to involve patients, to help them understand treatment options, and to work collaboratively to achieve goals of wellness.

When you and your doctor don’t see eye to eye on the best health care for you​

But what if you and your physician don’t agree on the best course of care for you? What if your doctor insists that she knows best, and that your health will be at risk if you don’t follow her advice? Maybe your physician has discouraged you from researching your medical condition yourself. From the physician’s angle, most of us want our patients to understand their illness, be educated on goals of wellness, and be active participants in their own healthcare. But here’s where it gets tricky: physicians study for years to become doctors and bring their scientific knowledge and clinical acumen to the office and the bedside. Patients may not have those skills, but they know their own bodies, tolerance for treatment, and the manner in which they are comfortable receiving care.

Finding the right doctor​

It’s sometimes hard to find a doctor you’re comfortable with, whether it’s for you or your child. Making a list of what’s important to you — whether you have a physician you like now, are uncomfortable in your current treating situation, or are in the process of looking for a new provider — can really help. Ask yourself these questions:
  • What is my style about health care? Do I want my doctor to tell me what to do, list the options but give me the final choice, or let me describe the medication and plan that I have researched first?
  • Would I like someone who is more relational or more boundaried? Do I want a physician who has the style of sharing his own life with me, asks about my life and tries to incorporate who I am as a person as well as a patient, or would I prefer a more businesslike approach? Do I want my physician to tell me if she has the same illness I do, and what it’s like for her, or would I prefer my doctor keep this to herself?
  • How much do I want my doctor to know about me as a person? Is that important in the way I want to receive my health care?
  • What might happen if I disagree with my doctor? Would that end the treating relationship right there, or could we work through a difference?

The right doctor will naturally support your patient autonomy​

Figuring out how you want your physician to work with you lets you maintain your patient autonomy, whatever that autonomy might be. Receiving the kind of care that is comfortable for you is exercising your autonomy. There will always be blips along the way. One woman told me about a primary care doctor she had worked with for years who became enraged with her at a visit, seemingly out of the blue. She felt he was attacking her health care behavior without asking appropriate questions. She offered him several opportunities during the visit to re-evaluate his comments. When he couldn’t do so, she used her autonomy to fire him. Another patient described being told that if he did not take a specific medication, the outcome could be devastating for his health. This may have been true, but perhaps a more collaborative discussion would have allowed this patient to feel less bullied into a treatment. Feeling comfortable with your right to get the answers you need to understand your treatment reflects your patient autonomy. Make sure your doctor’s style matches your own. How the treating relationship works is an essential part of the treatment. If it works, everything is enhanced. If your autonomy is not respected, your health care will suffer.
 
Back
Top